Fig. 2.
A: Locoregional progression-free survival. B:M0 versus M1. C: Well-/moderately differentiated versus poorly differentiated histology. D:External beam radiation therapy (EBRT) versus concurrent chemoradiation therapy (CCRT).
A: Locoregional progression-free survival. B:M0 versus M1. C: Well-/moderately differentiated versus poorly differentiated histology. D:External beam radiation therapy (EBRT) versus concurrent chemoradiation therapy (CCRT).